Japan-based NEC Corporation and Biomy, Inc. have signed a Memorandum of Understanding (MoU) for a joint market...
Japanese firm Kaneka Corporation has acquired 96.8% of shares of EndoStream Medical, an Israeli medical equipment compan...
Japan-based Kaken Pharmaceutical Co. has entered into a license agreement with Johnson & Johnson for the globa...
JCR Pharmaceuticals Co. and Modalis Therapeutics Corporation have validated the initial proof of concept ...
Takeda has announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA [Immun...
Fujirebio Holdings, a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., in Japan, have entered into a...
Japan's Sumitomo Chemical Co. and Sumitomo Pharma have studied restructuring measures to accelerate the development of r...
Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...
Japan-based Shimadzu Corporation has signed an investment contract with U-Medico Inc, a contract research organisation (...
Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for patients with dise...
Texas Medical Center (TMC), in the US, in partnership with Japan-based organisations Mitsui Fudosan Co. and&nb...
Israel-based Teva Pharmaceutical Industries has entered into an agreement with JKI, established by the fund managed and ...
SOHM, Inc., a globally recognised pharmaceutical company focused on developing, manufacturing and distributing Generic, ...
Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...
The Indian Institute of Technology (IIT) Roorkee and Kyoto University have announce the inauguration of a joint research...
US-based Kura Oncology, Inc. and Japanese pharmaceutical firm Kyowa Kirin have entered into a global strategic collabora...
Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with ...
Numab Therapeutics AG, a clinical stage biotechnology company advancing a proprietary pipeline of multi-specific antibod...
